Breaking
πŸ‡ΊπŸ‡Έ FDA
Whitepaper US Score 85/100

Scientific Standards for 23andMe's Health and Trait Reports

This white paper outlines the scientific standards for 23andMe's genetic health and trait reports, emphasizing validity and evidence-based practices.

Publisher
23andMe
Published
Length
8 pages
File
240 KB PDF
Scientific Standards for 23andMe's Health and Trait Reports β€” cover
⬇

Download the full 8-page PDF

Free Β· 240 KB Β· Instant access after email

πŸ”’ We never share your email. Single-click download.
# Executive Summary This white paper details the scientific standards employed by 23andMe for their Health and Trait reports, focusing on: - **Clinical and Analytical Validity**: Reports must meet strict standards for validity and reliability. - **Evidence Sources**: Genetic associations are based on peer-reviewed studies and clinical guidelines. - **Report Types**: Includes Carrier Status, Genetic Health Risk, and Pharmacogenetics reports, each with specific criteria for variant inclusion. - **Regulatory Compliance**: All reports are regulated by the U.S. FDA to ensure clinical and analytical validity. - **Evaluation Criteria**: Studies are assessed for population size, methodology, and statistical significance to ensure robust findings.

Ready to read the full report?

Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.

Download PDF ↓